Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Revealed
India's Third Giant Leap

This Could be One of the Biggest Opportunities for Investors




Important: We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
By submitting your email address, you also sign up for Profit Hunter, a daily newsletter from Equitymaster
covering exciting investing ideas and opportunities in India.

AD

MAX HEALTHCARE INSTITUTE 2023-24 Annual Report Analysis
Wed, 28 Aug

MAX HEALTHCARE INSTITUTE has announced its results for the year ended March 2024. Let us have a look at the detailed performance review of the company during FY23-24.

MAX HEALTHCARE INSTITUTE Income Statement Analysis

  • Operating income during the year rose 18.5% on a year-on-year (YoY) basis.
  • The company's operating profit increased by 20.7% YoY during the fiscal. Operating profit margins witnessed a fall and down at 27.4% in FY24 as against 26.9% in FY23.
  • Depreciation charges increased by 5.5% and finance costs decreased by 28.6% YoY, respectively.
  • Other income grew by 24.1% YoY.
  • Net profit for the year declined by 4.2% YoY.
  • Net profit margins during the year declined from 24.2% in FY23 to 19.6% in FY24.

MAX HEALTHCARE INSTITUTE Income Statement 2023-24

No. of Mths Year Ending 12 Mar-23* 12 Mar-24* % Change
Net Sales Rs m 45,626 54,060 18.5%
Other income Rs m 1,523 1,891 24.1%
Total Revenues Rs m 47,149 55,951 18.7%
Gross profit Rs m 12,275 14,811 20.7%
Depreciation Rs m 2,322 2,450 5.5%
Interest Rs m 839 599 -28.6%
Profit before tax Rs m 10,637 13,653 28.4%
Tax Rs m -398 3,077 NA
Profit after tax Rs m 11,035 10,576 -4.2%
Gross profit margin % 26.9 27.4
Effective tax rate % -3.7 22.5
Net profit margin % 24.2 19.6
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Accord Fintech, Equitymaster



Must See: These Segments are Witnessing Incredible Growth with Modi's Push

MAX HEALTHCARE INSTITUTE Balance Sheet Analysis

  • The company's current liabilities during FY24 stood at Rs 12 billion as compared to Rs 10 billion in FY23, thereby witnessing an increase of 19.4%.
  • Long-term debt stood at Rs 11 billion as compared to Rs 5 billion during FY23, a growth of 113.6%.
  • Current assets fell 12% and stood at Rs 17 billion, while fixed assets rose 26% and stood at Rs 103 billion in FY24.
  • Overall, the total assets and liabilities for FY24 stood at Rs 120 billion as against Rs 101 billion during FY23, thereby witnessing a growth of 19%.

MAX HEALTHCARE INSTITUTE Balance Sheet as on March 2024

No. of Mths Year Ending 12 Mar-23* 12 Mar-24* % Change
Networth Rs m 73,680 83,407 13.2
 
Current Liabilities Rs m 10,456 12,487 19.4
Long-term Debt Rs m 4,966 10,608 113.6
Total Liabilities Rs m 101,019 119,999 18.8
 
Current assets Rs m 19,431 17,062 -12.2
Fixed Assets Rs m 81,588 102,938 26.2
Total Assets Rs m 101,019 119,999 18.8
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Accord Fintech, Equitymaster



MAX HEALTHCARE INSTITUTE Cash Flow Statement Analysis

  • MAX HEALTHCARE INSTITUTE's cash flow from operating activities (CFO) during FY24 stood at Rs 11 billion on a YoY basis.
  • Cash flow from investing activities (CFI) during FY24 stood at Rs -13 billion, an improvement of 1,156.3% on a YoY basis.
  • Cash flow from financial activities (CFF) during FY24 stood at Rs -3 billion, an improvement of 9% on a YoY basis.
  • Overall, net cash flows for the company during FY24 stood at Rs -4 billion from the Rs 9 billion net cash flows seen during FY23.

MAX HEALTHCARE INSTITUTE Cash Flow Statement 2023-24

Particulars No. of months 12 12 % Change
Year Ending Mar-23 Mar-24
Cash Flow from Operating Activities Rs m 12,841 11,218 -12.6%
Cash Flow from Investing Activities Rs m -1,023 -12,855 -
Cash Flow from Financing Activities Rs m -2,886 -2,637 -
Net Cash Flow Rs m 8,934 -3,945 -
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Accord Fintech, Equitymaster



Current Valuations for MAX HEALTHCARE INSTITUTE

  • The trailing twelve-month earnings per share (EPS) of the company stands at Rs 10.9, an decline from the EPS of Rs 11.4 recorded last year.
  • The price to earnings (P/E) ratio, at the current price of Rs 855.8, stands at 78.9 times its trailing twelve months earnings.
  • The price to book value (P/BV) ratio at current price levels stands at 10.0 times, while the price to sales ratio stands at 15.4 times.
  • The company's price to cash flow (P/CF) ratio stood at 49.3 times its end-of-year operating cash flow earnings.

Per Share Data/Valuations

No. of Mths Year Ending 12 Mar-23* 12 Mar-24*
Sales per share (Unadj.) Rs 47.0 55.6
TTM Earnings per share Rs 11.4 10.9
Diluted earnings per share Rs 11.4 10.9
Price to Cash Flow x 32.1 49.3
TTM P/E ratio x 38.8 78.9
Price / Book Value ratio x 5.2 7.7
Market Cap Rs m 382,786 641,948
Dividends per share (Unadj.) Rs 1.0 1.5
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Accord Fintech, Equitymaster



Ratio Analysis for MAX HEALTHCARE INSTITUTE

  • Solvency Ratios
  • Current Ratio: The company's current ratio deteriorated and stood at 1.4x during FY24, from 1.9x during FY23. The current ratio measures the company's ability to pay short-term and long-term obligations.

    Interest Coverage Ratio: The company's interest coverage ratio improved and stood at 23.8x during FY24, from 13.7x during FY23. The interest coverage ratio of a company states how easily a company can pay its interest expense on outstanding debt. A higher ratio is preferable.

  • Profitability Ratios
  • Return on Equity (ROE): The ROE for the company declined and down at 12.7% during FY24, from 15.0% during FY24. The ROE measures the ability of a firm to generate profits from its shareholders capital in the company.

    Return on Capital Employed (ROCE): The ROCE for the company improved and stood at 15.2% during FY24, from 14.6% during FY23. The ROCE measures the ability of a firm to generate profits from its total capital (shareholder capital plus debt capital) employed in the company.

    Return on Assets (ROA): The ROA of the company declined and down at 9.3% during FY24, from 11.8% during FY23. The ROA measures how efficiently the company uses its assets to generate earnings.

Key Ratio Analysis

No. of Mths Year Ending 12 Mar-23* 12 Mar-24*
Current ratio x 1.9 1.4
Debtors’ Days Days 269 312
Interest coverage x 13.7 23.8
Debt to equity ratio x 0.1 0.1
Return on assets % 11.8 9.3
Return on equity % 15.0 12.7
Return on capital employed % 14.6 15.2
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Accord Fintech, Equitymaster



To see how MAX HEALTHCARE INSTITUTE has performed over the last 5 years, please visit here.

MAX HEALTHCARE INSTITUTE Share Price Performance

Over the last one year, MAX HEALTHCARE INSTITUTE share price has moved up from Rs 554.6 to Rs 855.8, registering a gain of Rs 301.2 or around 54.3%.

Meanwhile, the S&P BSE HEALTHCARE Index is trading at Rs 42,532.5 (up 0.4%). Over the last one year it has moved up from 27,859.6 to 42,532.5, a gain of 14,673 points (up 52.7%).

Overall, the S&P BSE SENSEX is up 26.0% over the year.

(To know more, check out historical annual results for MAX HEALTHCARE INSTITUTE and quarterly results for MAX HEALTHCARE INSTITUTE)

Annual Report FAQs

What is the current share price of MAX HEALTHCARE INSTITUTE?

MAX HEALTHCARE INSTITUTE currently trades at Rs 999.8 per share. You can check out the latest share price performance of MAX HEALTHCARE INSTITUTE here...

What was the revenue of MAX HEALTHCARE INSTITUTE in FY24? How does it compare to earlier years?

The revenues of MAX HEALTHCARE INSTITUTE stood at Rs 55,951 m in FY24, which was up 18.7% compared to Rs 47,149 m reported in FY23.

MAX HEALTHCARE INSTITUTE's revenue has grown from Rs 11,120 m in FY20 to Rs 55,951 m in FY24.

Over the past 5 years, the revenue of MAX HEALTHCARE INSTITUTE has grown at a CAGR of 49.8%.

What was the net profit of MAX HEALTHCARE INSTITUTE in FY24? How does it compare to earlier years?

The net profit of MAX HEALTHCARE INSTITUTE stood at Rs 10,576 m in FY24, which was down -4.2% compared to Rs 11,035 m reported in FY23.

This compares to a net profit of Rs 6,051 m in FY22 and a net loss of Rs -1,145 m in FY21.

Over the past 5 years, MAX HEALTHCARE INSTITUTE net profit has grown at a CAGR of 200.9%.

What does the cash flow statement of MAX HEALTHCARE INSTITUTE reveal?

The cash flow statement is the financial statement that presents the cash inflows and outflows of a company during a given period of time.

This statement is one of the most useful tools for judging a company's liquidity position. The ratios and parameters in this statement helps test a company's financial health.

The cash flow statement of MAX HEALTHCARE INSTITUTE reveals:

  • Cash flow from operations decreased in FY24 and stood at Rs 11,218 m as compared to Rs 12,841 m in FY23.
  • Cash flow from investments decreased in FY24 and stood at Rs -12,855 m as compared to Rs -1,023 m in FY23.
  • Cash flow from financial activity increased in FY24 and stood at Rs -2,637 m as compared to Rs -2,886 m in FY23.

Here's the cash flow statement of MAX HEALTHCARE INSTITUTE for the past 5 years.

(Rs m)FY20FY21FY22FY23FY24
From Operations7711,1797,40512,84111,218
From Investments-26,407-730-7,638-1,023-12,855
From Financial Activity23,5311,913-2,942-2,886-2,637
Net Cashflow-2,1055,156-3,1758,934-3,945

What does the Key Ratio analysis of MAX HEALTHCARE INSTITUTE reveal?

Be it the company's profitability, operations effectiveness or utilization of funds, ratio analysis is an important tool which helps in making investment decisions.

The ratio/financial analysis of MAX HEALTHCARE INSTITUTE reveals:

  • Operating profit margins witnessed a fall and down at 27.4% in FY24 as against 26.9% in FY23.
  • Net profit margins declined from 24.2% in FY23 to 19.6% in FY24.
  • Debt to Equity ratio for FY24 stood at 0.1 as compared to 0.1 in FY23.

Here's the ratio/financial analysis of MAX HEALTHCARE INSTITUTE for the past 5 years.

 FY20FY21FY22FY23FY24
Operating Profit Margin (%)8.46.023.626.927.4
Net Profit Margin (%)1.2-4.615.424.219.6
Debt to Equity Ratio (x)0.00.20.10.10.1

Equitymaster requests your view! Post a comment on "MAX HEALTHCARE INSTITUTE 2023-24 Annual Report Analysis". Click here!